
Pacific Edge soars on busy day for NZX
Cancer diagnostics company Pacific Edge soared more than 100% after improving its standing in the United States, and the New Zealand sharemarket gained nearly 0.5% on a busy day.
Cancer diagnostics company Pacific Edge soared more than 100% after improving its standing in the United States, and the New Zealand sharemarket gained nearly 0.5% on a busy day.